ロード中...

Effect of an oral gold compound, auranofin, on non-specific bronchial hyperresponsiveness in mild asthma.

BACKGROUND--A recent double blind clinical trial in Japan has shown that auranofin (6 mg/day) is a useful treatment for patients with moderate to severe asthma. To investigate the mechanism of action of auranofin the bronchial responsiveness to inhaled methacholine has been studied in well controlle...

詳細記述

保存先:
書誌詳細
主要な著者: Honma, M., Tamura, G., Shirato, K., Takishima, T.
フォーマット: Artigo
言語:Inglês
出版事項: 1994
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC475050/
https://ncbi.nlm.nih.gov/pubmed/8066558
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!